Guest guest Posted February 11, 2001 Report Share Posted February 11, 2001 CNN.com - Health - Long-sought drug said to fight sepsis - February 9, 2001 SEARCH CNN.com CNNSI.com CNNfn.com The Web CNN Sites CNN CNN Asia CNN Europe CNNfn CNNSI myCNN Education AllPolitics Languages MAINPAGE WORLD US WEATHER BUSINESS SPORTS POLITICS LAW SCI-TECH SPACE HEALTH ENTERTAINMENT TRAVEL CAREER LOCAL IN-DEPTH Click Here EDITIONS: CNN.com Asia CNN.com Europe set default edition MULTIMEDIA: video audio multimedia showcase more services E-MAIL: Subscribe to one of our news e-mail lists. Enter your address: DISCUSSION: message boards chat feedback CNN WEB SITES: CNNfyi.com CNN.com Europe CNN.com Asia Spanish Portuguese German Italian Swedish Norwegian Danish Japanese Chinese Headlines Korean Headlines TIME INC. SITES: Go To ... Time.com People Money Fortune EW CNN NETWORKS: CNN anchors transcripts distribution SITE INFO: search ad info jobs WEB SERVICES: Long-sought drug said to fight sepsis BOSTON, Massachusetts (AP) -- An international research team says it has discovered the first drug that successfully combats sepsis, a blood infection that kills about 225,000 Americans each year. Researchers have spent about 15 years looking for a drug to fight the disease. " From what we saw, this is a tremendous breakthrough, " said Dr. Matthay of the University of California in San Francisco. " This is truly a landmark trial. " Matthay reviewed the test results with other scientists for The New England Journal of Medicine. The findings were initially set to be published March 8, but the journal is releasing them earlier because of their medical importance. The research was carried out on 1,690 patients with severe sepsis at 164 locations in 11 countries. It was coordinated at Vanderbilt University in Nashville, Tennessee, and funded by Eli Lilly and Co. Much of the public has never heard of sepsis, even though about 750,000 cases are diagnosed in the U.S. each year, researchers say. Many medical problems give rise to sepsis, including pneumonia, trauma, surgical complications and cancer. Sepsis, a bacterial infection of the bloodstream, sets off a chain of chemical reactions that lead to excessive inflammation and clotting. It often causes death by destroying a patient's internal organs. The new drug is derived from a natural blood product known as activated protein C. In the blood, activated protein C curbs inflammation and clotting. Sepsis patients are currently treated with antibiotics, fluids and ventilators for lung failure. But no existing treatment directly attacks the blood infection. Dr. Goodman, a University of Washington researcher who has studied sepsis, said the new drug " gives us a new bullet to shoot at this disease. " In the study, half of the patients took the drug intravenously for four days, and the rest took a placebo. The patients were monitored for 28 days. While only 25 percent of the patients given the drug died, 31 percent died in the comparison group. Patients who took the drug had a 19 percent lesser chance of dying than the others. " It's been a terrible frustration as an intensive-care doctor to watch huge numbers of patients who develop sepsis, " said lead researcher Gordon Bernard of Vanderbilt. " This drug will be used widely for these patients. " Eli Lilly has applied for approval from the U.S. Food and Drug Administration, and plans to market the drug under the name Zovant. Bernard, who has acted as a consultant for Lilly, said approval could come within six months. Researchers in the study acknowledged that the drug may yield some negative side effects. Of the patients who took the drug, 3.5 percent developed serious bleeding, compared with 2 percent of placebo-takers. But doctors said even a 3.5 percent risk is fairly small. Still, they said the drug should not be given to patients who are susceptible to bleeding. They also said the drug has not yet been tested on children. Copyright 2001 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. -------------------------------------------------------------------------- RELATED STORIES: Potentially fatal germs under fingernails of hospital personnel should be 'eradicated,' study says September 7, 2000 New fabric may help fight transmittable diseases August 24, 1999 New York man dies after supergerm infection April 24, 1998 -------------------------------------------------------------------------- RELATED SITES: New England Journal of Medicine Eli Lilly and Co. Vanderbilt University Food and Drug Administration University of California San Francisco University of Washington Note: Pages will open in a new browser window External sites are not endorsed by CNN Interactive. -------------------------------------------------------------------------- Search CNN.com CNNSI.com CNNfn.com The Web HEALTH Genome study: Humans have remarkably few genes Australian doctors reject economy class syndrome Two indicted in deaths of nursing home patients Abuse of prescription painkiller spreads Pulled drugs may be riskier for women Lasting mental loss after heart surgery possible (MORE) -------------------------------------------------------------------------- -------------------------------------------------------------------------- TOP STORIES Astronauts explore Destiny Search for ship survivors resumes as hopes fade Appeals court to rule in Napster case Monday Genome study: Humans have remarkably few genes (MORE) -------------------------------------------------------------------------- BUSINESS When Greenspan speaks Napster: Another judgment day Riverstone leads IPO week (MORE) MARKETS 4:31pm ET, 2/9 DJIA 99.10 10781.40 NAS 91.09 2470.97 S & P 17.77 1314.76 -------------------------------------------------------------------------- SPORTS Gripes and injuries dominate NBA All-Star talk holds off Earnhardt to win Bud Shootout Rejuvenated Ga. Tech downs No. 6 Virginia, 62-56 (MORE) All Scoreboards -------------------------------------------------------------------------- WEATHER All cities -------------------------------------------------------------------------- WORLD Search for ship survivors resumes as hopes fade -------------------------------------------------------------------------- U.S. Astronauts explore Destiny -------------------------------------------------------------------------- ALLPOLITICS Burton seeks immunity for Marc Rich's ex-wife -------------------------------------------------------------------------- LAW Questionnaires yield portrait of bombings trial jury -------------------------------------------------------------------------- SCI-TECH Astronauts enter Destiny for first time -------------------------------------------------------------------------- ENTERTAINMENT Review: Grisham's 'Painted House' brightly done -------------------------------------------------------------------------- TRAVEL Delta pilots vote on whether to authorize strike -------------------------------------------------------------------------- CAREER Opening notes -------------------------------------------------------------------------- (MORE HEADLINES) Back to the top © 2001 Cable News Network. All Rights Reserved. Terms under which this service is provided to you. Read our privacy guidelines. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.